Diana McKenzie - MetLife Independent Director
| MET Stock | USD 71.11 1.16 1.66% |
Director
Ms. Diana McKenzie is Independent Director of the Company effective November 1, 2018. Prior to joining Workday, McKenzie served as senior vice president and chief information officer for Amgen Inc., the manufacturer of human therapeutics. She held various technology roles during her 12 years with the company, applying leadingedge analytics and technologies. McKenzie was an active leader in various trade, technology, and government organizations and was recognized as one of the Top 50 Most Powerful Women in Technology by the National Diversity Council, as well as one of the Top 25 Women Leaders in SaaS by the SaaS Report. since 2018.
| Age | 56 |
| Tenure | 6 years |
| Address | 200 Park Avenue, New York, NY, United States, 10166-0188 |
| Phone | 212 578 9500 |
| Web | https://www.metlife.com |
MetLife Management Efficiency
Return On Equity is likely to gain to 0.09 in 2024, whereas Return On Tangible Assets are likely to drop 0 in 2024. At this time, MetLife's Non Current Liabilities Total is comparatively stable compared to the past year. Change To Liabilities is likely to gain to about 5.4 B in 2024, whereas Total Current Liabilities is likely to drop slightly above 293.6 M in 2024. MetLife's management efficiency ratios could be used to measure how well MetLife manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Michael McLintock | Prudential Public Limited | 52 | |
| Constance Horner | Prudential Financial | 73 | |
| Timothy Keaney | Unum Group | 58 | |
| Tim Rolfe | Prudential Public Limited | N/A | |
| Mark FitzPatrick | Prudential Public Limited | 52 | |
| Susan DeVore | Unum Group | 62 | |
| Susan Dabarno | Manulife Financial Corp | 68 | |
| Lynn Utter | Lincoln National | 57 | |
| Christine Poon | Prudential Financial | 68 | |
| Michael Wells | Prudential Public Limited | 60 | |
| Ronald Hanley | Unum Group | 63 | |
| Deirdre Connelly | Lincoln National | 59 | |
| Gordon Bethune | Prudential Financial | 73 | |
| Takuro Yoshida | Aflac Incorporated | 62 | |
| Ellyn Brown | CNO Financial Group | 71 | |
| Anthony Nightingale | Prudential Public Limited | 73 | |
| Reginald Davis | Lincoln National | 57 | |
| Ming Lu | Prudential Public Limited | 62 | |
| Margaret McCarthy | Brighthouse Financial | 64 | |
| Mary Henderson | CNO Financial Group | 70 | |
| Isaiah Tidwell | Lincoln National | 73 | |
Management Performance
| Return On Equity | 0.0531 | ||||
| Return On Asset | 0.003 |
MetLife Leadership Team
Elected by the shareholders, the MetLife's board of directors comprises two types of representatives: MetLife inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MetLife. The board's role is to monitor MetLife's management team and ensure that shareholders' interests are well served. MetLife's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MetLife's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Catherine Kinney, Independent Director | ||
| Stephen Gauster, Senior Vice President Interim General Counsel | ||
| Michel Khalaf, President, Chief Executive Officer, Director | ||
| Bill Pappas, Executive Vice President Head of Global Technology and Operations | ||
| Diana McKenzie, Independent Director | ||
| Randy Stram, Senior Benefits | ||
| Cheryl Grise, Lead Independent Director | ||
| Maria Morris, Executive Vice President Head - Global Employee Benefits | ||
| Edward Spehar, Executive Vice President Treasurer | ||
| Kenton Sicchitano, Independent Director | ||
| John Hall, Senior Relations | ||
| John Hele, CFO and Executive VP | ||
| David Herzog, Independent Director | ||
| Graham Cox, Head of Retirement and Income Solutions | ||
| Robin Gordon, Chief Data and Analytics Officer | ||
| Randy Clerihue, Chief Communications Officer | ||
| Gerald Hassell, Independent Director | ||
| Tamara Schock, Executive Vice President Chief Accounting Officer | ||
| Steven Kandarian, Chairman of the Board and Presidentident, CEO | ||
| Jennifer Gottlieb, Head - Global Employee Communication | ||
| Ed Spehar, Executive Vice President Treasurer | ||
| Michael Farrell, Head EVP | ||
| Denise Morrison, Independent Director | ||
| Nuria Garcia, Head of EMEA | ||
| Christopher Townsend, President of Asia | ||
| Ricardo Anzaldua, Executive Vice President General Counsel | ||
| Mark Weinberger, Independent Director | ||
| Glenn Hubbard, Lead Independent Director | ||
| John McCallion, Chief Financial Officer, Executive Vice President | ||
| Kishore Ponnavolu, President - Asia Region | ||
| Randolph Clerihue, Chief Officer | ||
| Carlos Gutierrez, Independent Director | ||
| Michael Roberts, Executive Vice President Chief Marketing Officer | ||
| Pawan Verma, Executive Vice President, Chief Information Officer | ||
| Martin Lippert, Executive VP of Global Technology and Operations | ||
| Lyndon Oliver, Executive Vice President Treasurer | ||
| Ramy Tadros, Executive Vice President and President - U.S. Business | ||
| Alfred Kelly, Independent Director | ||
| William ODonnell, Executive Vice President Chief Accounting Officer | ||
| Susan MBA, Executive Officer | ||
| Robert Hubbard, Independent Chairman of the Board | ||
| William Kennard, Independent Director | ||
| Steven Goulart, Executive Vice President, Chief Investment Officer | ||
| Susan Podlogar, Chief Human Resource Officer, Executive Vice President | ||
| Robert Merck, Global MD | ||
| Cindy Pace, Global Chief Diversity and Inclusion Officer | ||
| William Moore, President Business | ||
| James Kilts, Independent Director | ||
| Esther Lee, Executive Vice President Global Chief Marketing Officer | ||
| Edward Kelly, Independent Director | ||
| Oscar Schmidt, President of Latin America | ||
| Frans Hijkoop, Chief Human Resource Officer, Executive Vice President | ||
| Marlene Debel, Executive Vice President, Chief Risk Officer | ||
| Lulu Wang, Independent Director | ||
| Timothy Ring, Chief Sustainability Officer | ||
| John CPA, Executive CFO |
MetLife Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MetLife a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0531 | ||||
| Return On Asset | 0.003 | ||||
| Profit Margin | 0.02 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 70.16 B | ||||
| Shares Outstanding | 723.02 M | ||||
| Shares Owned By Insiders | 16.40 % | ||||
| Shares Owned By Institutions | 75.95 % | ||||
| Number Of Shares Shorted | 7.36 M | ||||
| Price To Earning | 28.61 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MetLife. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. For more information on how to buy MetLife Stock please use our How to Invest in MetLife guide.Note that the MetLife information on this page should be used as a complementary analysis to other MetLife's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Money Managers module to screen money managers from public funds and ETFs managed around the world.
Complementary Tools for MetLife Stock analysis
When running MetLife's price analysis, check to measure MetLife's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MetLife is operating at the current time. Most of MetLife's value examination focuses on studying past and present price action to predict the probability of MetLife's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MetLife's price. Additionally, you may evaluate how the addition of MetLife to your portfolios can decrease your overall portfolio volatility.
| CEOs Directory Screen CEOs from public companies around the world | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |
Is MetLife's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of MetLife. If investors know MetLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about MetLife listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.61) | Dividend Share 2.06 | Earnings Share 1.81 | Revenue Per Share 88.295 | Quarterly Revenue Growth 0.219 |
The market value of MetLife is measured differently than its book value, which is the value of MetLife that is recorded on the company's balance sheet. Investors also form their own opinion of MetLife's value that differs from its market value or its book value, called intrinsic value, which is MetLife's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because MetLife's market value can be influenced by many factors that don't directly affect MetLife's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between MetLife's value and its price as these two are different measures arrived at by different means. Investors typically determine if MetLife is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, MetLife's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.